Lv6
1790 积分 2023-02-21 加入
A small fragment of factor B as a potential inhibitor of complement alternative pathway activity
7小时前
待确认
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
7小时前
待确认
Handbook of Drug Screening
15小时前
已完结
The landscape of small-molecule prodrugs
4天前
已完结
The Optimized Lipid-Modified Prodrug for CNV Treatment
5天前
已完结
Prediction of the pharmacokinetics of the GLP-1 receptor agonist semaglutide in humans via a population pharmacokinetic model integrating interspecies scaling
6天前
已完结
The Molecular Basis for the Delayed Absorption of the Once-Daily Human GLP-1 Analoge, Liraglutide
6天前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
8天前
已完结
Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy
12天前
已完结
Textbook of Drug Design and Discovery
13天前
已完结
皖公网安备34019202002308
